Efficacy of Adaptol and the possibility of its differential use in patients with anxiety disorders after myocardial infarction

Shilina N.N.

Volgogradskiĭ gosudarstvennyĭ meditsinskiĭ universitet Minzdrava Rossii;
Gorodskaia klinicheskaia bol'nitsa #3, Volgograd

Statsenko M.E.

Volgogradskiĭ gosudarstvennyĭ meditsinskiĭ universitet

ORCID: 0000-0002-3306-0312

Sporova O.E.

Volgogradskiĭ gosudarstvennyĭ meditsinskiĭ universitet Minzdrava Rossii;
Gorodskaia klinicheskaia bol'nitsa #3, Volgograd

Lempert B.A.

Volgogradskiĭ gosudarstvennyĭ meditsinskiĭ universitet Minzdrava Rossii;
Gorodskaia klinicheskaia bol'nitsa #3, Volgograd

Efficacy of Adaptol and the possibility of its differential use in patients with anxiety disorders after myocardial infarction

Authors:

Shilina N.N., Statsenko M.E., Sporova O.E., Lempert B.A.

More about the authors

Journal: Therapeutic Archive. 2013;85(9): 29‑34

Downloaded: 362

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Shilina NN, Statsenko ME, Sporova OE, Lempert BA. Efficacy of Adaptol and the possibility of its differential use in patients with anxiety disorders after myocardial infarction. Therapeutic Archive. 2013;85(9):29‑34. (In Russ.)

Close metadata

Recommended articles:

Advantages of long-term telemetric electrocardiogram monitoring in patients with myocardial infarction. Russian Cardiology Bulletin. 2024;(2):39-46

Posttraumatic stress disorder clinical guidelines and treatment standards: focus on the symptoms of the psychophysiological arousal. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):58-68

Asthenia in young patients and possibilities for its correction. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):133-137

Oral sedation in pediatric outpatient dentistry. Stomatology. 2024;(3):42-49

Patients with ischaemic heart disease and non-steroidal anti-inflammatory drugs dosing — recommendations and real-life clinical setting. Russian Journal of Preventive Medicine. 2024;(6):68-73

Trait and state anxiety, symptoms of insomnia and their influence on daytime functioning in adolescent girls. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5-2):66-71

The relationship between the specialized hospitals and departments medical doctors provision with myocardial infraction and cerebral stroke lethality. Russian Journal of Preventive Medicine. 2024;(7):30-37

Recognan (citicoline) in the correction of asthenic and anxiety-depressive disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):43-47

The association of single-nucleotide polymorphism rs6265 of the brain-derived neurotrophic factor gene with clinical features in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):82-88

To study the effectiveness and impact on the quality of life of patients with subclinical and clinically pronounced anxiety disorder of a mobile application in combination with Adaptol therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):98-105

Aim. To evaluate the efficacy and safety of adaptol in a dose of 1500-2000 mg/day in combination therapy for anxiety disorders (AD) in the early post-myocardial infarction period. Subjects and methods. The trial included 94 patients with AD who were divided into a study group of 60 patients and a control group of 34 patients. In addition to basic therapy, the study group took adaptol in a dose of 1500-200 mg/day for 30±2 days; the control group received basic therapy only. Results. The drug given in a dose of 1500-2000 mg/day in the patients with AD in the early post-myocardial infarction period was found to have high anxiolytic, autonomically normalizing, stress-protective activities and a positive effect on heart rate variability just one month after treatment. The highest efficacy of Adaptol was observed in patients with baseline hypersympathicotonic and normal autonomic responsiveness. Conclusion. Adaptol proved to be more effective in patients with baseline hypersympathicotonic and normal autonomic responsiveness, which permits the drug to be differentially used in relation to the baseline type of autonomic responsiveness.

Keywords:

adaptol

anxiety

myocardial infarction

Authors:

Shilina N.N.

Volgogradskiĭ gosudarstvennyĭ meditsinskiĭ universitet Minzdrava Rossii;
Gorodskaia klinicheskaia bol'nitsa #3, Volgograd

Statsenko M.E.

Volgogradskiĭ gosudarstvennyĭ meditsinskiĭ universitet

ORCID: 0000-0002-3306-0312

Sporova O.E.

Volgogradskiĭ gosudarstvennyĭ meditsinskiĭ universitet Minzdrava Rossii;
Gorodskaia klinicheskaia bol'nitsa #3, Volgograd

Lempert B.A.

Volgogradskiĭ gosudarstvennyĭ meditsinskiĭ universitet Minzdrava Rossii;
Gorodskaia klinicheskaia bol'nitsa #3, Volgograd

List of references:

Vasyuk Yu.A., Lebedev A.V., Dovzhenko T.V., Semiglazova M.V. Affektivnye rasstroistva pri ostrom infarkte miokarda i vozmozhnosti ikh korrektsii tianeptinom. Ter arkh 2010; 10: 28-33.
Tarasevich E.V. Svyaz' trevogi i depressii s obshchesomaticheskimi zabolevaniyami. Psikhiatr, psikhoter i klin psikhol 2012; 2: 123-137.
Ibrahimagic O.C., Sinanovic O., Smajlovic D. Anxiety in acute phase of ischemic stroke and myocardial infarction. Med Arh 2005; 59 (6) 366-369.
Kirichenko A.A., Ebzeeva E.Yu. Znachenie raspoznavaniya trevozhno-depressivnykh rasstroistv v klinike vnutrennikh boleznei. Consilium Medicum 2012; 5: 113-114.
Kop W.J., Stein P.K., Tracy R.P. et al. Autonomic nervous system dysfunction and inflammation contribute to the increased cardiovascular mortality risk associated with depression. Psychosom Med 2010; 72 (7): 626-635.
Balukova E.V., Uspenskii Yu.P., Tkachenko E.I. Trevozhnye rasstroistva u bol'nykh terapevticheskogo profilya. Ter arkh 2007; 6: 85-88.
Doletskii A.A., Svet A.V., Chaplygin A.V. i dr. Psikhologicheskaya reabilitatsiya kardiologicheskikh bol'nykh. Kardiol i serdechno-sosudistaya khir 2011; 1: 31-36.
Mallik S., Spertus J.A., Reid K.J. et al. Depressive symptoms after acute myocardial infarction: evidence for highest rates in younger women. Arch Intern Med 2006; 166 (8): 876-883.
Nicholson A., Kuper H., Hemingway H. Depression as an aeliologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146538 participants in 54 observational studies. Eur Heart J 2006; 27: 2763-2774.
Taylor D. Antidepressant drugs and cardiovascular pathology, a clinical overview of effectiveness and safety. Acta Psychiatr Scand 2008; 118: 434-442.
Manev H., Manev R. 5-lipoxygenase as a possible biological link between depressive symptoms and atherosclerosis. Arch Gen Psychiatry 2007; 64: 1333.
Slefanatou A., Kouris N.. Lekakis J. Treatment of depression in elderly patients with cardiovascular disease, research data and future prospects. Hellenic J Cardiol 2010; 51: 142-152.
Carney R., Blumenthal J., Stein P. et al. Depression, heart rate variability, and acute myocardial infarction. Circulation 2011; 104: 2024-2028.
Galyautdinova V.R., Mutalova E.G., Rustyamova Z.Ya. Depressiya u bol'nykh ishemicheskoi bolezn'yu serdtsa i ikh terapevticheskaya korrektsiya. Kardiol i serdechno-sosudistaya khir 2012; 5: 25-30.
Statsenko M.E., Rybak V.A., Govorukha O.A. Korrektsiya trevozhno-depressivnykh rasstroistv tianeptinom u bol'nykh s khronicheskoi serdechnoi nedostatochnost'yu v postinfarktnom periode. Kardiologiya 2005; 12: 48-52.
Statsenko M.E., Shilina N.N. Primenenie tsitaloprama v vosstanovitel'nom periode infarkta miokarda u patsientov s sakharnym diabetom 2 tipa i affektivnymi rasstroistvami. Ros kardiol zhurn 2008; 4: 56-60.
Statsenko M.E., Shilina N.N. Terapiya posle infarkta miokarda u patsientov s affektivnymi rasstroistvami i sakharnym diabetom tipa 2. Vrach 2012; 4: 94-98.
Chutko L.S., Rozhkova A.V., Sidorenko V.A. i dr. Generalizovannoe trevozhnoe rasstroistvo: psikhosomaticheskie podkhody k lecheniyu. Zhurn nevrol i psikhiatr 2012; 1: 40-44.
Pollack M.H. Refractory generalized anxiety disorder. J Clin Psychiatry 2009; 70: Suppl 2: 32-38.
Statsenko M.E., Sporova O.E., Govorukha O.A. i dr. Effektivnost' primeneniya fenazepama v sostave kompleksnoi terapii u bol'nykh s trevozhno-depressivnymi rasstroistvami v rannem postinfarktnom periode. Byul Volgogradskogo nauchnogo tsentra RAMN 2009; 3: 29-33.
Mkrtchyan V.R., Orlov V.A., Kozhokova L.Z. Vozmozhnosti primeneniya adaptola v klinicheskoi praktike. Kardiol i serdechno-sosudistaya khir 2012; 6: 27-32.
Statsenko M.E., Sporova O.E., Kolodyazhnaya O.I., Evtereva E.D. Effektivnost' primeneniya adaptola v kompleksnoi terapii u bol'nykh s trevozhnymi rasstroistvami v rannem postinfarktnom periode. Kardiol i serdechno-sosudistaya khir 2009; 5: 18-22.
Statsenko M.E., Sporova O.E., Shilina N.N. i dr. Terapevticheskie vozmozhnosti adaptola v rannem postinfarktnom periode u bol'nykh s trevozhnymi rasstroistvami. Kardiol i serdechno-sosudistaya khir 2011; 4: 41-47.
Petrova N., Kutuzova A., Bobrovskaya E. Medikamentoznaya korrektsiya trevozhnykh rasstroistv u bol'nykh ostrym infarktom miokarda. Vrach 2010; 7: 53-55.
Tyshchenko I.A. Osobennosti techeniya postinfarktnogo perioda u pozhilykh bol'nykh s khronicheskoi serdechnoi nedostatochnost'yu v zavisimosti ot vyrazhennosti affektivnykh rasstroistv i ikh medikamentoznoi korrektsii: Avtoref. dis. … kand. med. nauk. Volgograd 2008; 27.
Andryushchenko A.V., Drobizhev M.Yu., Dobrovol'skii A.V. Sravnitel'naya otsenka shkal CES-D, BDI i HADS (d) v diagnostike depressii v obshchemeditsinskoi praktike. Zhurn nevrol i psikhiatr 2003; 103: 11-18.
Kopina O.S. Pokazateli psikhosotsial'nogo stressa pri stenokardii i arterial'noi gipertonii. Mater. Vsesoyuz. simpoz. "Mnogofaktornaya profilaktika IBS". Tomsk 1989; 76.
Chalder T., Berelowitz G., Pawlikowska T. et. al. Development of a fatique scale. J Psychosomatic Res 1993; 37: 147-153.
Levin Ya.I., Sadykov E.T. Zolpidem v lechenii narushenii sna u bol'nykh ishemicheskim insul'tom. Zhurn nevrol i psikhiatr 2000; 3: 44-47.
Babunts I.V., Miridzhanyan E.M., Mashaekh Yu.A. Azbuka analiza variabel'nosti serdechnogo ritma. Stavropol': Printmaster 2002; 112.
Belenkov Yu.N., Mareev V.Yu. Printsipy ratsional'nogo lecheniya serdechnoi nedostatochnosti. M: Media Medika 2001; 266

Close metadata